Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022

Eur Urol. 2023 Jul;84(1):7-8. doi: 10.1016/j.eururo.2023.03.028. Epub 2023 Apr 7.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Dipeptides
  • Humans
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms*
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • PSMA-617
  • Lutetium-177
  • Prostate-Specific Antigen
  • Dipeptides